Clinical trial
APACC Study:Prospective Study on Aspirin Efficacy in Reducing Colorectal Adenoma…
NCT00224679 · Assistance Publique - Hôpitaux de Paris, Other · Terminated
Key facts
| NCT number | NCT00224679 |
|---|---|
| Title | APACC Study:Prospective Study on Aspirin Efficacy in Reducing Colorectal Adenoma Recurrence |
| Official title | Prospective Study on Aspirin Efficacy in Reducing Colorectal Adenoma Recurrence |
| Lead sponsor | Assistance Publique - Hôpitaux de Paris, Other |
| Collaborators | Société Nationale Française de Gastroentérologie Ministry of Health, France Sanofi-Synthelabo Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Colon Adenomas |
| Intervention type | Drug |
| Interventions | Aspirin |
| Enrollment | 300 |
| Start date | Mar 1, 1997 |
| Completion | Mar 1, 1999 |
| First posted | Sep 23, 2005 |
| Last update posted | Jun 5, 2012 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: